Cited by 675Uterine Myomas and TreatmentsRenal cell carcinoma treatmentTuberous Sclerosis Complex Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Open access

Launonen, Virpi, Vierimaa, Outi, Kiuru, Maija, Isola, Jorma, Roth, Stina, Pukkala, Eero, Sistonen, Pertti, Herva, Riitta, Aaltonen, Lauri A.·2001·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.051633798PMC PMC30663

Open this paper in CoChat — free account

Abstract

Herein we report the clinical, histopathological, and molecular features of a cancer syndrome with predisposition to uterine leiomyomas and papillary renal cell carcinoma. The studied kindred included 11 family members with uterine leiomyomas and two with uterine leiomyosarcoma. Seven individuals had a history of cutaneous nodules, two of which were confirmed to be cutaneous leiomyomatosis. The four kidney cancer cases occurred in young (33- to 48-year-old) females and displayed a unique natural history. All these kidney cancers displayed a distinct papillary histology and presented as unilateral solitary lesions that had metastasized at the time of diagnosis. Genetic-marker analysis mapped the predisposition gene to chromosome 1q. Losses of the normal chromosome 1q were observed in tumors that had occurred in the kindred, including a uterine leiomyoma. Moreover, the observed histological features were used as a tool to diagnose a second kindred displaying the phenotype. We have shown that predisposition to uterine leiomyomas and papillary renal cell cancer can be inherited dominantly through the hereditary leiomyomatosis and renal cell cancer ( HLRCC ) gene. The HLRCC gene maps to chromosome 1q and is likely to be a tumor suppressor. Clinical, histopathological, and molecular tools are now available for accurate detection and diagnosis of this cancer syndrome.

Integrity signals

Registry

Crossref · 10.1073/pnas.051633798

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J. R., Yao, M., Duh, F.-M. C., Orcutt, M. L., Stackhouse, T. M., Kuzmin, I., Modi, W. S., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,971
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L. S., Duh, F.-M. C., Chen, F., Kishida, T., Glenn, G. M., Choyke, P. L., Scherer, S. W., Zhuang, Z., Lubensky, I. A., Dean, M. C., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,517
Faster sequential genetic linkage computations.
Cottingham, R. W., Idury, R. M., & Schäffer, A. A. (1993) · Europe PMC (PubMed Central) · Cited by 1,364
Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
Delahunt, B., & Eble, J. N. (1997) · PubMed · Cited by 714
Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland
Teppo, L., Pukkala, ., & Lehtonen, M. (1994) · Acta Oncologica · doi:10.3109/02841869409098430 · Cited by 648
Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation
Cohen, A. J., Li, F. P., Berg, S., Marchetto, D. J., Tsai, S., Jacobs, S. C., & Brown, R. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197909133011107 · Cited by 643
Tumors of the Kidney, Bladder, and Related Urinary Structures
Murphy, W. M., Grignon, D. J., & Perlman, E. J. (2004) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/1881041883 · Cited by 433
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
Yeung, R. S. W., Xiao, G. H., Jin, F., Lee, W. C., Testa, J. R., & Knudson, A. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11413 · Cited by 307

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 7

O Iliopoulos, C Eng Semin Oncol 27, 138–149 (2000).
C D Malchoff, M Sarfarazi, B Tendler, F Forouhar, G Whalen, V Joshi, A Arnold, D M Malchoff J Clin Endocrinol Metab 85, 1758–1764 (2000).
B Delahunt, J N Eble Mod Pathol 10, 537–544 (1997).
L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
R W Cottingham, R M Idury, A A Schaffer Am J Hum Genet 53, 252–263 (1993).
J I Everitt, D C Wolf, S R Howe, T L Goldsworthy, C Walker Am J Pathol 146, 1556–1567 (1995).
V E Reuter, J C Presti Semin Oncol 27, 124–137 (2000).

Sorted by citations

Items 101–200 of 675

The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer
Ciccarone, F., Vegliante, R., Leo, L. D., & Ciriolo, M. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.06.008 · Cited by 97
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals
Forde, C., Lim, D., Alwan, Y., Burghel, G. J., Butland, L., Cleaver, R., Dixit, A., Evans, D. G., Hanson, H., Lalloo, F. I., et al. (2019) · European Urology Oncology · doi:10.1016/j.euo.2019.11.002 · Cited by 95
Molecular and Cellular Insights into the Development of Uterine Fibroids
Machado-Lopez, A., Simón, C., & Mas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168483 · Cited by 103
Aerobic glycolysis: a novel target in kidney cancer
Shuch, B. M., Linehan, W. M., & Srinivasan, R. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/era.13.57 · Cited by 95
Pseudohypoxic Pathways in Renal Cell Carcinoma
Bratslavsky, G., Sudarshan, S., Neckers, L., & Linehan, W. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2510 · Cited by 93
Rare insights into cancer biology
Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 90
Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability
Välimäki, N., Kuisma, H., Pasanen, A. M., Heikinheimo, O., Sjöberg, J., Bützow, R. C., Sarvilinna, N. S., Heinonen, H.-R., Tolvanen, J., Bramante, S., et al. (2018) · eLife · doi:10.7554/elife.37110 · Cited by 92
Self-citation
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer
Yehia, L., Niazi, F., Ni, Y., Ngeow, J. Y. Y., Sankunny, M., Liu, Z., Wei, W., Mester, J. L., Keri, R. A., Zhang, B., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.001 · Cited by 90
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Gleeson, J. P., Nikolovski, I., DiNatale, R. G., Zucker, M. R., Knežević, A., Patil, S., Ged, Y. M. A., Kotecha, R. R., Shapnik, N., Murray, S. J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4367 · Cited by 88
Analysis of fumarate hydratase mutations in a population‐based series of early onset uterine leiomyosarcoma patients
Ylisaukko‐oja, S. K., Kiuru, M. H., Lehtonen, H. J., Lehtonen, R., Pukkala, ., Arola, J. T., Launonen, V., & Aaltonen, L. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21798 · Cited by 88
Self-citation
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions
Guitart, A. V., Panagopoulou, T. I., Villacreces, A., Vukovic, M., Sepulveda, C., Allen, L., Carter, R. N., van de Lagemaat, L. N., Morgan, M., Giles, P., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161087 · Cited by 86
Gender aspects in skin diseases
Chen, W., Mempel, M., Traidl‐Hoffmann, C., Khusaei, S. A., & Ring, J. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03668.x · Cited by 90
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
MED12 exon 2 mutations in histopathological uterine leiomyoma variants
Mäkinen, N., Vahteristo, P., Kämpjärvi, K., Arola, J. T., Bützow, R. C., & Aaltonen, L. A. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.33 · Cited by 85
Self-citation
Familial risk of cancer by site and histopathology
Hemminki, K., & Li, X. (2002) · International Journal of Cancer · doi:10.1002/ijc.10764 · Cited by 87
Genetic heterogeneity among uterine leiomyomata: insights into malignant progression
Hodge, J. C., & Morton, C. C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm043 · Cited by 83
African Ancestry and Genetic Risk for Uterine Leiomyomata
Wise, L. A., Ruiz-Narváez, E., Palmer, J. R., Cozier, Y. C., Tandon, A., Patterson, N. J., Radin, R. G., Rosenberg, L. A., & Reich, D. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws276 · Cited by 82
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Ooi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.016 · Cited by 85
Adrenal Nodular Hyperplasia in Hereditary Leiomyomatosis and Renal Cell Cancer
Shuch, B. M., Ricketts, C. J., Vocke, C. D., Valera, V., Chen, C. C., Gautam, R., Gupta, G. N., Gómez-Macias, G. S., Merino, M. J., Bratslavsky, G., et al. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.07.139 · Cited by 83
Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome)
Buelow, B., Cohen, J. N., Nagymányoki, Z., Frizzell, N., Joseph, N. M., McCalmont, T. H., & Garg, K. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000626 · Cited by 81
Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases
Bennett, J. A., Weigelt, B., Chiang, S., Selenica, P., Chen, Y., Bialik, A., Bi, R., Schultheis, A. M., Lim, R. S., Ng, C. K. Y., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.56 · Cited by 78
The Surgical Approach to Multifocal Renal Cancers: Hereditary Syndromes, Ipsilateral Multifocality, and Bilateral Tumors
Shuch, B. M., Singer, E. A., & Bratslavsky, G. (2012) · Urologic Clinics of North America · doi:10.1016/j.ucl.2012.01.006 · Cited by 78
Missense Mutations in Fumarate Hydratase in Multiple Cutaneous and Uterine Leiomyomatosis and Renal Cell Cancer
Alam, N. A., Olpin, S. E., Rowan, A., Kelsell, D. P., Leigh, I. M., Tomlinson, I. P. M., & Weaver, T. M. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60574-0 · Cited by 74
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 75
The Genetics of Uterine Leiomyomata
Stewart, E. A., & Morton, C. C. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000206161.84965.0b · Cited by 72
Germline Fumarate Hydratase Mutations in Families with Multiple Cutaneous and Uterine Leiomyomata
Martı́nez-Mir, A., Gläser, B., Chuang, G. S., Horev, L., Waldman, A., Engler, D. E., Gordon, D., Spelman, L. J., Hatzibougias, I., Green, J., et al. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12499.x · Cited by 72
Distinct expression profile in fumarate-hydratase-deficient uterine fibroids
Vanharanta, S., Pollard, P. J., Lehtonen, H. J., Laiho, P., Sjöberg, J., Leminen, A., Aittomäki, K., Arola, J. T., Kruhøffer, M., Orntoft, T. F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi431 · Cited by 73
Self-citation
Molecular Genetics of Familial Renal Cell Carcinoma Syndromes
Cohen, D., & Zhou, M. (2005) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2005.01.003 · Cited by 71
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes
Ponti, G., Pellacani, G., Seidenari, S., Pollio, A., Muscatello, U., & Tomasi, A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.07.001 · Cited by 71
Targeting the Met signaling pathway in renal cancer
Giubellino, A., Linehan, W. M., & Bottaro, D. P. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.43 · Cited by 71
Cutaneous Manifestations of Internal Malignancy
Ehst, B. D., Minzer-Conzetti, K., Swerdlin, A., & Devere, T. S. (2010) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2010.01.003 · Cited by 69
HIF and fumarate hydratase in renal cancer
Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 70
Precision medicine from the renal cancer genome
Riazalhosseini, Y., & Lathrop, M. G. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.133 · Cited by 69
Enzymatic features of the glucose metabolism in tumor cells
Herling, A., König, M., Bulik, S., & Holzhütter, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08174.x · Cited by 70
A Rapid and Simple Procedure for the Establishment of Human Normal and Cancer Renal Primary Cell Cultures from Surgical Specimens
Valente, M. J., Henrique, R., Costa, V. L., Jerónimo, C., Carvalho, F. D., Bastos, M. D. L., de Pinho, P. G., & Carvalho, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019337 · Cited by 67
Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: Genetic linkage analysis and FISH studies
Gross, K. L., Panhuysen, C. I. M., Kleinman, M. S., Goldhammer, H., Jones, E. S., Nassery, N., Stewart, E. A., & Morton, C. C. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20079 · Cited by 67
Nephron-sparing surgery for multifocal and hereditary renal tumors
Metwalli, A. R., & Linehan, W. M. (2014) · Current Opinion in Urology · doi:10.1097/mou.0000000000000094 · Cited by 67
Renal Acidification Mechanisms
Weiner, I. D., Verlander, J. W., & Wingo, C. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3770-3_7 · Cited by 66
Studying Cancer Families to Identify Kidney Cancer Genes
Zbar, B., Klausner, R. D., & Linehan, W. M. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152514 · Cited by 66
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy
Pfaffenroth, E. C., & Linehan, W. M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.6.779 · Cited by 67
A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer
Yang, Y., Valera, V., Sourbier, C., Vocke, C. D., Wei, M., Pike, L., Huang, Y. K., Merino, M. A., Bratslavsky, G., Wu, M., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.05.001 · Cited by 67
Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification
Udager, A. M., & Mehra, R. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0218-ra · Cited by 66
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening
Siegler, L., Erber, R., Burghaus, S., Brodkorb, T., Wachter, D. L., Wilkinson, N., Bolton, J., Stringfellow, H. F., Haller, F., Beckmann, M. W., et al. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2292-6 · Cited by 69
Bacteria, yeast, worms, and flies: Exploiting simple model organisms to investigate human mitochondrial diseases
Rea, S. L., Graham, B. H., Nakamaru‐Ogiso, E., Kar, A., & Falk, M. J. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.114 · Cited by 68
Mechanisms of Disease: hereditary leiomyomatosis and renal cell cancer—a distinct form of hereditary kidney cancer
Sudarshan, S., Pinto, P. A., Neckers, L., & Linehan, W. M. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0711 · Cited by 63
Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes
Adam, J., Ramracheya, R. D., Chibalina, M. V., Ternette, N., Hamilton, A., Tarasov, A. I., Zhang, Q., Rebelato, E., Rorsman, N. J. G., Martín-del-Río, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.093 · Cited by 61
What’s new in the WHO 2022 classification of kidney tumours?
Alaghehbandan, R., Siadat, F., & Trpkov, K. (2023) · Pathologica · doi:10.32074/1591-951x-818 · Cited by 62
Comparative Proteomic Approach Identifies Pkm2 and Cofilin-1 as Potential Diagnostic, Prognostic and Therapeutic Targets for Pulmonary Adenocarcinoma
Peng, X., Gong, F., Zhao, Y., Zhou, L., Xie, Y., Liao, H.-L., Lin, H., Li, Z., Tang, M., & Tong, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027309 · Cited by 60
Hidden features: exploring the non-canonical functions of metabolic enzymes
Huangyang, P., & Simon, M. C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.033365 · Cited by 60
Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata
Chuang, G. S., Martı́nez-Mir, A., Geyer, A. S., Engler, D. E., Gläser, B., Cserhalmi‐Friedman, P. B., Gordon, D., Horev, L., Lukash, B., Herman, E., et al. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.051 · Cited by 60
Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets
Iliopoulos, O. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8948 · Cited by 59
The clinical implications of the genetics of renal cell carcinoma
Rosner, I. L., Bratslavsky, G., Pinto, P. A., & Linehan, W. M. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.11.001 · Cited by 56
Renal Acidification Mechanisms
Weiner, I. D., & Verlander, J. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10009-0 · Cited by 58
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer
Wilde, B. R., Chakraborty, N., Matulionis, N., Hernandez, S., Ueno, D., Gee, M. E., Esplin, E. D., Ouyang, K., Nykamp, K., Shuch, B. M., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0874 · Cited by 57
Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient
Alrashdi, I., Levine, S., Paterson, J., Saxena, R., Patel, S. R., Depani, S., Hargrave, D. R., Pritchard‐Jones, K., & Hodgson, S. V. (2009) · Familial Cancer · doi:10.1007/s10689-009-9306-0 · Cited by 57
Fumarase: From the TCA Cycle to DNA Damage Response and Tumor Suppression
Leshets, M., Silas, Y., Lehming, N., & Pines, O. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00068 · Cited by 57
A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature
Liu, F. W., Galvan-Turner, V. B., Pfaendler, K. S., Longoria, T. C., & Bristow, R. E. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.01.012 · Cited by 56
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma
Skala, S. L., Dhanasekaran, S. M., & Mehra, R. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0216-ra · Cited by 57
Epidemiology of Renal Cell Carcinoma
Kümmerlin, I. P. E. D., Laguna, M. P., de la Rosette, J. J. M. C. H., & Bossuyt, P. M. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_1 · Cited by 56
Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele
Hodge, J. C., Cuenco, K. T., Huyck, K. L., Somasundaram, P., Panhuysen, C. I. M., Stewart, E. A., & Morton, C. C. (2009) · Human Genetics · doi:10.1007/s00439-008-0621-6 · Cited by 54
Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma
Alrefae, M., Wong, N., Patenaude, F., Bégin, L. R., & Foulkes, W. D. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0773 · Cited by 55
Lessons from the skin—cutaneous features of familial cancer
Winship, I., & Dudding, T. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70126-8 · Cited by 54
Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer
Pithukpakorn, M., Wei, M.-H., Toure, O., Steinbach, P. J., Glenn, G. M., Zbar, B., Linehan, W. M., & Toro, J. R. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041087 · Cited by 55
Smooth Muscle Tumors of the Female Genital Tract
Devereaux, K. A., & Schoolmeester, J. K. (2019) · Surgical pathology clinics · doi:10.1016/j.path.2019.02.004 · Cited by 55
Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion
Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O’Neill, C. F., Parekh, D. J., Yeh, I., Sun, L., & Block, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 53
Protein lysine acetylation guards metabolic homeostasis to fight against cancer
Xu, W., Li, Y., LIU, C., & Zhao, S. (2013) · Oncogene · doi:10.1038/onc.2013.163 · Cited by 53
Epigenomic and enhancer dysregulation in uterine leiomyomas
Mlodawska, O. W., Saini, P., Parker, J. B., Wei, J., Bulun, S. E., Simon, M. A., & Chakravarti, D. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac008 · Cited by 54
Genetic Basis of Cancer of the Kidney
Sudarshan, S., & Linehan, W. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.06.008 · Cited by 50
Recent Developments in the Pathology of Renal Tumors: Morphology and Molecular Characteristics of Select Entities
Yan, B. C., Mackinnon, A. C., & Al‐Ahmadie, H. A. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.7.1026 · Cited by 50
Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer
Chan, I., Wong, T., Martı́nez-Mir, A., Christiano, A. M., & McGrath, J. A. (2005) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01675.x · Cited by 52
Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC)
Udager, A. M., Alva, A. S., Chen, Y., Siddiqui, J., Lagstein, A., Tickoo, S. K., Reuter, V. E., Chinnaiyan, A. M., & Mehra, R. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000127 · Cited by 51
Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
Chan, E., Rabban, J. T., Mak, J. S., Zaloudek, C. J., & Garg, K. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001293 · Cited by 51
Towards a new WHO classification of renal cell tumor: what the clinician needs to know—a narrative review
Cimadamore, A., Liang Cheng, C., Scarpelli, M., Massari, F., Mollica, V., Santoni, M., Antonio Lopez-beltran, B., Montironi, R., & Moch, H. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1150 · Cited by 50
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
Kämpjärvi, K., Mäkinen, N., Mehine, M. M., Välipakka, S., Uimari, O., Pitkänen, E., Heinonen, H.-R., Heikkinen, T., Tolvanen, J., Ahtikoski, A. M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.130 · Cited by 49
Self-citation
Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome
Rabban, J. T., Chan, E., Mak, J. S., Zaloudek, C. J., & Garg, K. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001222 · Cited by 51
Renal cell carcinoma in young FH mutation carriers: case series and review of the literature
Hol, J. A., Jongmans, M. C. J., Littooij, A. S., de Krijger, R. R., Kuiper, R. P., van Harssel, J. J. T., Mensenkamp, A. R., Simons, M., Tytgat, G. A. M., van den Heuvel‐Eibrink, M. M., et al. (2019) · Familial Cancer · doi:10.1007/s10689-019-00155-3 · Cited by 48
Conventional renal cancer in a patient with fumarate hydratase mutation
Lehtonen, H. J., Blanco, I., Piulats, J. M., Herva, R., Launonen, V., & Aaltonen, L. A. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.10.011 · Cited by 50
Self-citation
Functional implications of fumarate-induced cysteine succination
Guberović, I., & Frezza, C. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.05.003 · Cited by 52
Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas
Seo, A. N., Yoon, G., & Ro, J. Y. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000138 · Cited by 47
Uterine fibroids
Bulun, S. E., Yin, P., Wei, J., Zuberi, A., Iizuka, T., Suzuki, T., Saini, P., Goad, J., Parker, J. B., Adli, M., et al. (2025) · Physiological Reviews · doi:10.1152/physrev.00010.2024 · Cited by 61
Hereditary and familial kidney cancer
Coleman, J., & Russo, P. (2009) · Current Opinion in Urology · doi:10.1097/mou.0b013e32832f0d40 · Cited by 46
Human Fumarate Hydratase Is Dual Localized by an Alternative Transcription Initiation Mechanism
Dik, E., Naamati, A., Asraf, H., Lehming, N., & Pines, O. (2016) · Traffic · doi:10.1111/tra.12397 · Cited by 44
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 47
Familial adult renal neoplasia
Takahashi, M., Kahnoski, R. J., Gross, D., Nicol, D. L., & Teh, B. T. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.1 · Cited by 47
Leiomyoma Cutis: A Focused Review on Presentation, Management, and Association with Malignancy
Malik, K., Patel, P. S., Chen, J., & Khachemoune, A. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0112-1 · Cited by 45
The genetic basis of renal cell carcinoma
Pavlovich, C. P., Schmidt, L. S., & Phillips, J. L. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(03)00023-5 · Cited by 46
Neoplasms of the Kidney
MacLennan, G. T., & Liang Cheng, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-23380-2_35 · Cited by 43
Next generation immunohistochemistry: Emerging substitutes to genetic testing?
Andrici, J., Gill, A. J., & Hornick, J. L. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.05.004 · Cited by 44
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer
Shuch, B. M., Li, S., Risch, H. A., Bindra, R. S., McGillivray, P. D., & Gerstein, M. (2020) · Cancer · doi:10.1002/cncr.32914 · Cited by 45
Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda, N., Toi, M., Hiroi, M., & Enzan, H. (2003) · PubMed · doi:10.14670/hh-18.487 · Cited by 44
Adult Renal Cell Carcinoma
Hirsch, M. S., Signoretti, S., & Cin, P. D. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.09.003 · Cited by 43
Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids
Chen, I., Firth, B., Hopkins, L., Bougie, O., Xie, R., & Singh, S. S. (2018) · JSLS Journal of the Society of Laparoscopic & Robotic Surgeons · doi:10.4293/jsls.2017.00066 · Cited by 43
The Genetic Heterogeneity of Uterine Leiomyomata
Lobel, M. K., Somasundaram, P., & Morton, C. C. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2005.12.006 · Cited by 43
The genetic basis of cancer of kidney cancer: implications for gene‐specific clinical management
Linehan, W. M., Grubb, R. L., Coleman, J., Zbar, B., & Walther, M. M. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05189.x · Cited by 43
Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes
Carter, C. S., Skala, S. L., Chinnaiyan, A. M., McHugh, J. B., Siddiqui, J., Cao, X., Dhanasekaran, S. M., Fullen, D. R., Lagstein, A., Chan, M. P., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000840 · Cited by 44
Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
Linehan, W. M., Srinivasan, R., & Garcia, J. A. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.05.009 · Cited by 42
Familial Leiomyomatosis: A Review and Discussion of Pathogenesis
Garman, M., Blumberg, M., Ernst, R., & Raimer, S. (2003) · Dermatology · doi:10.1159/000071802 · Cited by 39
Familial Renal Cancer: Molecular Genetics and Surgical Management
Barrisford, G. W., Singer, E. A., Rosner, I. L., Linehan, W. M., & Bratslavsky, G. (2011) · International Journal of Surgical Oncology · doi:10.1155/2011/658767 · Cited by 40
Exomic landscape of MED12 mutation‐negative and ‐positive uterine leiomyomas
Mäkinen, N., Vahteristo, P., Bützow, R. C., Sjöberg, J., & Aaltonen, L. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28410 · Cited by 40
Self-citation
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 38

Authors: Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A.
Affiliations: University of Helsinki (FI)
Department of Medical Genetics, Haartman Institute, University of Helsinki, P. O. Box 21, FIN-00014, Helsinki, Finland; Department of Clinical Genetics, Oulu University Hospital, Kajaanintie 50, FIN-90220, Oulu, Finland; Institute of Medical Technology, University of Tampere, FIN-33014, Tampere, Finland; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry, FIN-00170, Helsinki, Finland; Finnish Red Cross Blood Transfusion Service,...
ORCID: Kiuru, Maija
Isola, Jorma
Pukkala, Eero
Aaltonen, Lauri A.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2001-02-27
Volume: 98
Issue: 6
Pages: 3387-3392
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.051633798
PMC: PMC30663
OpenAlex: W2110394707
Cited by: 669
References: 24
Citations by year: 2026: 9 · 2025: 21 · 2024: 21 · 2023: 27 · 2022: 23 · 2021: 35 · 2020: 30 · 2019: 38 · 2018: 33 · 2017: 40 · 2016: 30 · 2015: 47 · 2014: 27 · 2013: 35 · 2012: 30
FWCI: 18.01
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Keywords: hereditary leiomyomatosis and renal cell carcinoma, uterine fibroids, papillary renal cell carcinoma, uterine leiomyosarcoma, tumor suppressor, hereditary cancer predisposition, dominant inheritance, metastatic renal cell carcinoma, histopathological diagnosis
MeSH terms: Adult, Carcinoma, Renal Cell, Chromosomes, Human, Female, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Leiomyosarcoma, Male, Middle Aged, Pedigree, Phenotype, Uterine Neoplasms, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inherited susceptibility to uterine leiomyomas and renal cell cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks